Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fecal Microbiota Transplantation vs Steroid Therapy in Severe Alcoholic Hepatitis
NCT03091010Unknown
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Apr 2017
- Primary completion
- Mar 2019
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised, open-label trial of Fecal Microbiota Transplantation Capsule in alcoholic hepatitis (AH) (2 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Overall Survival at 3 months. Status: unknown.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
alcoholic hepatitis (AH)
Beyond the preview
Go deeper on NCT03091010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03091010.